title: [Protective effect of compound bismuth and magnesium granules on aspirin-induced gastric mucosal injury in rats].
abstract: OBJECTIVE
  To investigate the protective effect of compound bismuth and magnesium granules on aspirin-induced gastric mucosal injury in rats and its possible mechanism.
  
  
  METHODS
  Acute gastric mucosal injury model was developed with intraperitoneal injection of aspirin in Wistar rats. The rats were divided into normal control group, injury group, sucralfate protection group, compound bismuth and magnesium granules protection group and its herbal components protection group(each group 12 rats). In the protection groups, drugs as mentioned above were administered by gavage before treated with intraperitoneal injection of aspirin. To evaluate the extent of gastric mucosal injury and the protective effect of drugs, gastric mucosal lesion index, gastric mucosal blood flow, content of gastric mucosal hexosamine, prostaglandins (PG), nitric oxide(NO), tumor necrosis factor (TNF), and interleukin (IL) -1, 2, 8 were measured in each group, and histological changes were observed by gross as well as under microscope and electron microscope.
  
  
  RESULTS
  Contents of hexosamine, NO, and PG in all the protection groups were significantly higher than those in the injury group (all P<0.01), and content of NO in the compound bismuth and magnesium granules group was significantly higher than that in the sucralfate group ((11.29±0.51) vs(10.80±0.36)nmol/ml, P<0.05). The gastric mucosal lesion index, contents of TNF, and IL-1, 2, 8 were significantly lower in all the protection groups than in the injury group (all P<0.01), and contents of IL-2 and IL-8 in the compound bismuth and magnesium granules group were significantly lower than those in the sucralfate group ((328.17±6.56) vs(340.23±8.05)pg/ml, P<0.01; (170.82±7.31) vs(179.31±7.80)pg/ml, P<0.05). Tissue injury and inflammatory reaction in all the protection groups were obviously mitigated compared with the injury group.
  
  
  CONCLUSIONS
  Compound bismuth and magnesium granules and its herbal components may have significant protective effect on aspirin-induced gastric mucosal injury.
authors.affiliation: Department of Gastroenterology, Aerospace Center Hospital, Beijing 100049, China.
authors.forename: F H
authors.initials: FH
authors.lastname: Mu
authors.forename: F L
authors.initials: FL
authors.lastname: Hu
authors.forename: H
authors.initials: H
authors.lastname: Wei
authors.forename: Y Y
authors.initials: YY
authors.lastname: Zhang
authors.forename: G B
authors.initials: GB
authors.lastname: Yang
authors.forename: X Y
authors.initials: XY
authors.lastname: Lei
authors.forename: Y P
authors.initials: YP
authors.lastname: Yang
authors.forename: W N
authors.initials: WN
authors.lastname: Sun
authors.forename: M H
authors.initials: MH
authors.lastname: Cui
mesh_terms: D000818:Animals; D000863:Antacids / Q000494:pharmacology*; D001241:Aspirin / Q000009:adverse effects*; D001729:Bismuth / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000187:drug effects* / Q000293:injuries / Q000473:pathology; D007249:Inflammation / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D008274:Magnesium; D008276:Magnesium Hydroxide / Q000494:pharmacology*; D009569:Nitric Oxide / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D013272:Stomach Diseases; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D000863:Antacids; D007375:Interleukin-1; D007376:Interleukin-2; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D008274:Magnesium; D008276:Magnesium Hydroxide; D001241:Aspirin; D001729:Bismuth